Caught on the wrong foot
24/06/20 -"Solvay’s €1.5bn impairment of the back of the current challenging business situation is the price the current management has to pay for the predecessor’s expensive decisions. The ..."
Pages
59
Language
English
Published on
24/06/20
You may also be interested by these reports :
17/10/25
Yara’s Q3 2025 results were mixed, with sales slightly below (1.8%) and EBITDA above (2.7%) market estimates – the latter supported by lower input ...
16/10/25
The change in the target price is due to a change in the analyst covering the stock, complemented by the usage of systematic intrinsic and peer-based ...
07/10/25
The improvement in our target has primarily been driven by the increase in earnings. In particular, the peer valuation has been impacted by our new ...
30/09/25
The improvement in our target is primarily driven by the increase in earnings. The peer valuation has been especially impacted due to our new ...